(Q44517333)

3 December 2017

Effects of truncated angiotensins in humans after double blockade of the renin system (English)

1 reference

Niels-Henrik von Holstein-Rathlou

3 December 2017

5

1 reference

Poul Flemming Høilund-Carlsen

3 December 2017

6

object named as

Poul Flemming Hoilund-Carlsen

1 reference

3 December 2017

Ronni R Plovsing

1

1 reference

3 December 2017

Christian Wamberg

2

1 reference

3 December 2017

Niels C F Sandgaard

3

1 reference

3 December 2017

Jane A Simonsen

4

1 reference

3 December 2017

Peter Bie

7

1 reference

3 December 2017

17 July 2003

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

3 December 2017

1 reference

3 December 2017

285

1 reference

3 December 2017

5

1 reference

3 December 2017

R981-91

1 reference

Synthesis and effects of active fragments of angiotensin II.

3 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Counterregulatory actions of angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

AT4 receptors: specificity and distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Dissociation between the renal effects of angiotensin I and II in sodium-restricted normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

A comparison between endogenous and exogenous lithium clearance in the anaesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Angiotensin and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Aldosterone response to long term infusion of angiotensin II and angiotensin III in conscious dogs before and after dietary sodium restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Bioactive angiotensin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Mechanisms of acute natriuresis in normal humans on low sodium diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Toward an Integrative Concept of Control of Total Body Sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Angiotensin II attenuates the natriuresis of water immersion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Central venous pressure--a physiological stimulus for secretion of atrial natriuretic peptide in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

[des-Asp1]angiotensin II in the dog: blood levels and effect on aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

The angiotensin IV system: functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00263.2003

10.1152/AJPREGU.00263.2003

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference